[Pe-021] English Poster Session 021

[Pe-021-2] The design of METEOROID: A phase 3 trial of satralizumab in patients with MOGAD

Yuji Tomizawa¹, Friedemann Paul², Eoin P. Flanagan³, Tania Kumpfel⁴, Romain Marignier⁵, Kazuo Fujihara⁶, Cheryl Hemingway⁷, Ivana Vodopivec⁸, Daniela Stokmaier⁸, Kristina Weber⁸, Michael Levy⁹ (1.Juntendo University, School of Medicine, Department of Neurology, Japan, 2.Charite-Universitatsmedizin Berlin, Germany, 3.Mayo Clinic, USA, 4.Institute of Clinical Neuroimmunology, University Hospital, LMU, Munich, Germany, 5.The University Hospital of Lyon, France, 6.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, School of Medicine, Japan, 7.GOSH and ICH, London, UK, 8.Roche, Switzerland, 9.MGH, USA)